Magnetospirillum magneticum triggers apoptotic pathways in human breast cancer cells

• Published in: Cancer & metabolism 2023-08, Vol.11 (1), p.12-12, Article 12
• Main Authors: Menghini, Stefano, Vizovisek, Matej, Enders, Jonathas, Schuerle, Simone
• Format: Article
• Language: English
• Subjects: Acids; Analysis; Apoptosis; Bacteria; Bacterial infections; Breast cancer; Cancer; Cancer cells; Cancer therapies; Cancer therapy; Care and treatment; Cell culture; Cell cycle; Cellular proliferation; Experiments; Health aspects; Hypoxia; Immunotherapy; International economic relations; Iron; Magnetotactic bacteria; Penicillin; Proteins; Scientific equipment and supplies industry; Tumors
• ISSN: 2049-3002; 2049-3002
• DOI: 10.1186/s40170-023-00313-3

The use of bacteria in cancer immunotherapy has the potential to bypass many shortcomings of conventional treatments. The ability of anaerobic bacteria to preferentially accumulate and replicate in hypoxic regions of solid tumors, as a consequence of bacterial metabolic needs, is particularly advantageous and key to boosting their immunostimulatory therapeutic actions in situ. While several of these bacterial traits are well-studied, little is known about their competition for nutrients and its effect on cancer cells which could serve as another potent and innate antineoplastic action. Here, we explored the consequences of the iron-scavenging abilities of a particular species of bacteria, Magnetospirillum magneticum, which has been studied as a potential new class of bacteria for magnetically targeted bacterial cancer therapy. We investigated their influence in hypoxic regions of solid tumors by studying the consequential metabolic effects exerted on cancer cells. To do so, we established an in vitro co-culture system consisting of the bacterial strain AMB-1 incubated under hypoxic conditions with human breast cancer cells MDA-MB-231. We first quantified the number of viable cells after incubation with magnetotactic bacteria demonstrating a lower rate of cellular proliferation that correlated with increasing bacteria-to-cancer cells ratio. Further experiments showed increasing populations of apoptotic cells when cancer cells were incubated with AMB-1 over a period of 24 h. Analysis of the metabolic effects induced by bacteria suggest an increase in the activation of executioner caspases as well as changes in levels of apoptosis-related proteins. Finally, the level of several human apoptosis-related proteins was investigated, confirming a bacteria-dependent triggering of apoptotic pathways in breast cancer cells. Overall, our findings support that magnetotactic bacteria could act as self-replicating iron-chelating agents and indicate that they interfere with proliferation and lead to increased apoptosis of cancer cells. This bacterial feature could serve as an additional antineoplastic mechanism to reinforce current bacterial cancer therapies.